Bills › 131st Legislature (2023–24)
LD 2096
An Act To Ensure Access To Nonopioid, Nonnarcotic Medication For Acute Pain Relief
Became law · sponsored by Troy Jackson · text and history at the Legislature
Who lobbied on it
9 clients whose lobbyists named LD 2096 in their monthly reports, with the pay they attributed to it (not their position). Linked: clients who also gave to two or more 2026 candidates.
| Client | Lobbyists | Months | Pay attributed |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | Katherine Knox | 2 | $1,388.33 |
| CIGNA | Charles C. Soltan, Charles Soltan | 5 | $0 |
| Elevance Health, Inc., and its affiliates including Anthem Health Plans of Maine | Kristine Ossenfort | 3 | $0 |
| Elevance Health, and its Affiliates D/B/A Anthem Blue Cross & Blue Shield | Bruce Gerrity | 1 | $0 |
| Healthcare Purchaser Alliance of Maine | Lisa Nolan | 1 | $0 |
| Maine Association of Health Plans | Dan Demeritt | 2 | $0 |
| Maine Hospital Association | Jeffrey Austin | 4 | $0 |
| Maine Medical Association | Anne Sedlack | 1 | $0 |
| Pharmaceutical Care Management Association | Keith Herrick, Sam Hallemeier | 3 | $0 |